GAMBLE JONES INVESTMENT COUNSEL - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,008 filers reported holding NOVARTIS A G in Q4 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.

Quarter-by-quarter ownership
GAMBLE JONES INVESTMENT COUNSEL ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2022$13,002,665
+17.7%
143,327
-1.4%
0.98%
+9.0%
Q3 2022$11,051,000
-9.7%
145,389
+0.5%
0.90%
-0.3%
Q2 2022$12,233,000
-5.1%
144,715
-1.5%
0.90%
+12.2%
Q1 2022$12,895,000
-0.3%
146,944
-0.7%
0.80%
+5.2%
Q4 2021$12,937,000
+7.4%
147,906
+0.4%
0.76%
-3.0%
Q3 2021$12,043,000
-9.8%
147,267
+0.6%
0.79%
-8.9%
Q2 2021$13,353,000
+6.7%
146,348
-0.1%
0.87%
+2.9%
Q1 2021$12,517,000
-7.7%
146,428
+1.9%
0.84%
-9.0%
Q4 2020$13,563,000
+8.9%
143,630
+0.2%
0.92%
+2.1%
Q3 2020$12,459,000
-1.5%
143,275
-1.0%
0.91%
-10.5%
Q2 2020$12,645,000
+5.1%
144,779
-0.8%
1.01%
-8.7%
Q1 2020$12,033,000
-13.7%
145,937
-0.9%
1.11%
+1.9%
Q4 2019$13,939,000
+7.4%
147,204
-1.4%
1.09%
+2.0%
Q3 2019$12,975,000
-3.6%
149,312
+1.3%
1.07%
-7.5%
Q2 2019$13,465,000
-4.4%
147,467
+0.7%
1.15%
-7.6%
Q1 2019$14,081,000
+15.8%
146,468
+3.3%
1.25%
+2.0%
Q4 2018$12,164,000
+0.1%
141,755
+0.5%
1.22%
+8.9%
Q3 2018$12,155,000
+20.5%
141,073
+5.6%
1.12%
+11.0%
Q2 2018$10,087,000
-5.3%
133,537
+1.4%
1.01%
-4.5%
Q1 2018$10,649,000
+12.5%
131,711
+16.8%
1.06%
+17.6%
Q4 2017$9,468,000
-2.0%
112,767
+0.2%
0.90%
-8.9%
Q3 2017$9,666,000
+0.8%
112,592
-2.0%
0.99%
-1.6%
Q2 2017$9,591,000
+6.4%
114,909
-5.3%
1.00%
+5.8%
Q1 2017$9,010,000
+1.6%
121,318
-0.3%
0.95%
-3.5%
Q4 2016$8,867,000
-8.2%
121,732
-0.5%
0.98%
-6.0%
Q3 2016$9,656,000
-0.2%
122,285
+4.3%
1.05%
-0.7%
Q2 2016$9,676,000
+95.1%
117,265
+71.3%
1.05%
+91.3%
Q1 2016$4,959,000
-16.7%
68,460
-1.1%
0.55%
-16.1%
Q4 2015$5,954,000
-9.3%
69,200
-3.1%
0.66%
-13.0%
Q3 2015$6,562,000
-12.7%
71,388
-6.6%
0.76%
-3.5%
Q2 2015$7,520,000
-2.4%
76,466
-2.2%
0.78%
-2.5%
Q1 2015$7,708,000
+4.2%
78,166
-2.1%
0.80%
+5.0%
Q4 2014$7,395,000
-3.1%
79,811
-1.5%
0.76%
-9.5%
Q3 2014$7,629,000
+5.0%
81,046
+1.0%
0.84%
+4.1%
Q2 2014$7,264,000
+3.4%
80,242
-2.9%
0.81%
-0.7%
Q1 2014$7,025,000
+2.9%
82,632
-2.7%
0.82%
+1.6%
Q4 2013$6,827,000
+2.0%
84,932
-2.7%
0.80%
-6.5%
Q3 2013$6,693,000
+5.2%
87,250
-3.0%
0.86%
+2.5%
Q2 2013$6,360,00089,9400.84%
Other shareholders
NOVARTIS A G shareholders Q4 2017
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 335,936$29,213,0005.81%
Martin Investment Management, LLC 170,759$14,849,0005.36%
Mawer Investment Management Ltd. 8,515,391$740,498,0004.84%
SCHARF INVESTMENTS, LLC 1,212,354$105,426,0004.54%
Hansberger Growth Investors, LP 45,645$3,969,0004.50%
GARLAND CAPITAL MANAGEMENT INC 50,905$4,427,0003.95%
First Fiduciary Investment Counsel, Inc. 193,021$16,785,0003.49%
PROFESSIONAL ADVISORY SERVICES INC 224,087$19,487,0003.48%
WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC 362,047$31,484,0003.29%
WILKINS INVESTMENT COUNSEL INC 126,470$10,998,0003.28%
View complete list of NOVARTIS A G shareholders